Last Updated on July 17, 2024 by The Health Master
USFDA
Lupin Limited, a leading global pharmaceutical company, has secured a significant win with the U.S. Food and Drug Administration (USFDA) granting its Dabhasa manufacturing facility (Gujarat, India) a clean bill of health.
This achievement underscores Lupin’s unwavering commitment to delivering high-quality, affordable generic drugs and Active Pharmaceutical Ingredients (APIs) to patients worldwide.
Flawless Inspection, Flawless Results
The USFDA conducted a thorough inspection of the Dabhasa facility from April 8th to 12th, 2024.
The inspection culminated in an Establishment Inspection Report (EIR) with the coveted classification of “No Action Indicated” (NAI).
This signifies that the USFDA found no observations regarding compliance or quality standards.
Lupin Manufacturing Solutions
The Dabhasa facility falls under the umbrella of Lupin Manufacturing Solutions (LMS).
LMS is a dedicated division of Lupin that focuses on the development, manufacturing, and commercialization of APIs while simultaneously building a robust Contract Development and Manufacturing Operations (CDMO) business.
This strategic move allows Lupin to not only produce its own high-quality medications but also partner with other pharmaceutical companies to bring innovative drugs to market.
Lupin’s unwavering commitment to quality
- Nilesh Gupta, Managing Director of Lupin, expressed his satisfaction with the EIR, highlighting the company’s relentless pursuit of the highest quality and compliance standards across all its operations.
- Investment in Excellence: Lupin dedicates a significant portion of its revenue (7.8% in FY24) to research and development (R&D), ensuring a steady pipeline of innovative and effective medications.
- Global Reach: Lupin is a transnational pharmaceutical leader headquartered in Mumbai, India. It has a presence in over 100 markets across the globe, catering to patients in the U.S., India, South Africa, Asia Pacific (APAC), Latin America (LATAM), Europe, and the Middle East.
- Diverse Portfolio: The company offers a vast array of branded and generic formulations, biotechnology products, and APIs. They specialize in crucial therapeutic areas like cardiovascular, anti-diabetic, and respiratory health while maintaining a strong presence in anti-infective, gastrointestinal (GI), central nervous system (CNS), and women’s health segments.
- Manufacturing Prowess: Lupin boasts an impressive infrastructure with 15 state-of-the-art manufacturing facilities strategically located across the globe, along with 7 dedicated research centers.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA grants VAI classification to Cipla at Maharashtra
USFDA inspection concluded with positive report at Alkem
USFDA issues positive EIR to Lupin Limited
USFDA issues Form 483 with 4 observations to Biocon
USFDA issues Form 483 with 6 observations to Cipla for Goa facility
USFDA inspection concluded at Lupin with zero observations
Drug Rules to include excipient details in drug labels
USFDA approval granted for the drug for the treatment of Migraine
USFDA grants VAI classification to Cipla at Maharashtra
Stricter Regulations on Schedule G Drug Ads in India
Gist of the draft notification: Compounding of Offences under the Drugs and Cosmetics Act
Govt Considers Price Control on Nutraceuticals in India
Maharashtra FDA conducts raids at three different locations in Vasai
Telangana DCA seizes illegally stocked and overpriced medicines
USFDA approval granted for this chronic heart failure treatment drug
PCI frames new Regulations in accordance with Jan Vishwas Act
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
